Gurjeet is a Consultant Ophthalmic Surgeon at Oxford University Hospital. He has a sub-specialty interest in glaucoma and complex cataract surgery. As the department lead for glaucoma at the John Radcliffe, he provides minimally invasive glaucoma surgery (MIGS), endoscopic cyclophotocoagulation laser treatments and conventional glaucoma surgery (including trabeculectomy and tube surgeries).Gurjeet completed his ophthalmology training at North Thames deanery, spending five years at Moorfields and Western Eye hospitals. A University College London Ophthalmology MSc lecturer, he has authored the influential textbook ‘Ophthalmology at a Glance’ and set exams for the International Council of Ophthalmology. A winner of five postgraduate prizes, he has been responsible for various global presentations, peer-reviewed publications and textbook chapters. Accolades received by Gurjeet include being named as a Novartis Glaucoma Award finalist, with this case being published in the prestigious peer-reviewed journal BMC.
He has been the glaucoma department lead at Oxford University Hospital since early 2018, reshaping the virtual service provided to patients and working closely alongside the lead optometrist to develop a protocol to transfer patients to from the clinic to the service safely. Each virtual assessment is reviewed by Gurjeet personally to ensure safety standards are constantly upheld. The minimally invasive glaucoma surgery (MIGS) service provided by the Trust was also developed by Gurjeet, with Oxford University Hospital being one of only twenty UK centres providing cyclophotocoagulation (ECP). He is a high output surgeon, responsible for 482 intra-ocular surgeries (including 401 cataract surgeries) last year. His posterior capsular rupture rate is far lower than national average (0.41% versus 2%).
Gurjeet has a strong teaching pedigree, providing monthly teaching sessions at the Oxford Association for the Blind, participating in the regional teaching of Oxford Deanery trainees and running weekly departmental glaucoma/cataract sessions. His efforts were recognised by being awarded trainer of the month twice in his first year at the Oxford University Hospital Trusts (2018). He is a lecturer at the MSc Clinical Ophthalmology, Institute of Ophthalmology and a member of the International Council of Ophthalmology examination committee alongside five other consultants, devising questions on glaucoma for the yearly ICO exam. He is an invited speaker both Nationally and Internationally at numerous workshops and conferences. He is a principle investigator for an on-going trial at the JR looking at different modalities of drug delivery for glaucoma patients.
Cataracts, glaucoma, MIGS, general ophthalmology.
- Laser peripheral iridotomy
- Laser YAG capsulotomy
- Aqueous shunt (tube) surgery: this will always be under general anaesthetic
- Surgical Trabeculectomy
- Endoscopic Cyclophotocoagulation (ECP)
- Minimally invasive glaucoma surgery (Xen implants)
Treatments and tests offered by Mr Gurjeet Jutley at Nuffield Health
- Cataract surgery
Mr Jutley was a co-investigator for the landmark DARC phase II, TAGS and Simbrinza studies, during his two years at Imperial College. Currently his research interests include managing rubeotic glaucoma and prospective outcomes from MIGS.
- European Society of Cataract and Refractive Surgeons
- Royal College of Ophthalmologists
- Association for Research in Vision and Ophthalmology
Other post held
- Consultant Ophthalmic Surgeon, Oxford Eye Hospital and Witney Community Hospital
Insurers Mr Gurjeet Jutley works with
Mr Gurjeet Jutley works with the following private medical insurance providers:
- Aviva Health
Mr Gurjeet Jutley does not hold a share or financial interest in this hospital, another Nuffield Health hospital or the company.
Mr Gurjeet Jutley does not have a share or financial interest in equipment used at this hospital or another Nuffield Health hospital.
Mr Gurjeet Jutley does not hold any paid advisory role(s) at this hospital or on behalf of Nuffield Health.